Clínica Baviera, S.A. (BME:CBAV)

Market Cap	951.50M +53.6%
Revenue (ttm)	304.91M +14.7%
Net Income	42.06M +4.6%
EPS	2.63 +4.5%
Shares Out	16.02M
PE Ratio	22.61
Forward PE	n/a
Dividend	1.57 (2.64%)
Ex-Dividend Date	Jun 10, 2026

Volume	6,673
Open	58.00
Previous Close	57.80
Day's Range	57.60 - 59.40
52-Week Range	38.10 - 59.80
Beta	0.76
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 9, 2026

About Clínica Baviera

Clínica Baviera, S.A., a medical company, operates a network of ophthalmology clinics in Spain and Europe. The company is involved in the diagnosis, treatment, and monitoring of various types of visual disorders. Its clinics offers myopia, hyperopia, astigmatism, farsightedness, presbyopia, cataract, retinal, plastic surgery, pediatric ophthalmology, glaucoma, strabismus, cornea, neuro-ophthalmology, tear ducts, oculoplasty, lasik, and intraocular lenses treatments. The company was formerly known as Clínica Oftalmológica Baviera, S.L. and chang...

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1992
• Employees: 1,910
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: CBAV

Financial Performance

In 2025, Clínica Baviera's revenue was 304.91 million, an increase of 14.75% compared to the previous year's 265.72 million. Earnings were 42.06 million, an increase of 4.62%.